FDA Grants Priority Review To Flu Drug.

NBC News (6/26, Fox) reports on its website that the Food and Drug Administration granted priority review to Genentech’s flu drug baloxavir marboxil. The article adds that if approved, “baloxavir would be the first new flu drug to hit the U.S. market in...